Literature DB >> 2106549

The significance of infections with two types of viral hepatitis demonstrated by histologic features in chimpanzees.

H P Dienes1, R H Purcell, H Popper, A Ponzetto.   

Abstract

In view of the recognized importance of necroinflammatory episodes in chronic hepatitis B virus (HBV) infection, chimpanzees, either HBV surface antigen (HBsAg) carriers or noninfected (naive), were infected with other primary hepatotropic viruses to evaluate histologic alterations and changes in virologic and biochemical markers of infection. The advantages of studies on chimpanzees are the availability of serial biopsy specimens and the viral type-specific histologic lesions, not as well recognized in humans. Infection with hepatitis A and non-A, non-B (NANB) agents produced more severe lesions in chronic HBsAg carrier chimpanzees than in naive animals. During this superinfection, the specific expression of the second agent was predominant, indicating that the exacerbation is caused by the second agent, but that carriers are prone to more severe disease than the naive chimpanzees. Hepatitis delta virus (HDV) infections were always coexistant with HBV and superinfection of carriers produced histologic changes more severe than those seen in any other type of viral hepatitis. Such HDV infections revealed less evidence of lymphocytotoxicity but rather of cytotoxicity, and sometimes resembled in appearance the histopathology of NANB. Coinfection of HDV and HBV and superinfection of HBV-carriers with NANB resulted in hepatitis that was far less severe than superinfection of HDV in HBV carriers, greatly in keeping with human experiences. HBV replication was suppressed transiently in both NANB and HDV superinfection. This implies that in exacerbations during chronic HBV infections of humans, suppression of HBV replication markers indicates superinfection, for instance, by NANB for which markers are so far not widely available; by contrast, elevated markers of HBV replication suggest reactivation of the original HBV infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106549     DOI: 10.1016/0168-8278(90)90076-4

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  11 in total

Review 1.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

2.  Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics.

Authors:  Ingmar Mederacke; Birgit Bremer; Benjamin Heidrich; Janina Kirschner; Katja Deterding; Thomas Bock; Karsten Wursthorn; Michael P Manns; Heiner Wedemeyer
Journal:  J Clin Microbiol       Date:  2010-03-29       Impact factor: 5.948

3.  Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections.

Authors:  J T Guo; H Zhou; C Liu; C Aldrich; J Saputelli; T Whitaker; M I Barrasa; W S Mason; C Seeger
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Transfusion-associated hepatitis before the screening of blood for hepatitis risk factors.

Authors:  Ronald E Engle; Jens Bukh; Harvey J Alter; Suzanne U Emerson; Joni L Trenbeath; Hanh T Nguyen; Alicia Brockington; Tanaji Mitra; Robert H Purcell
Journal:  Transfusion       Date:  2014-05-05       Impact factor: 3.157

Review 5.  Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead.

Authors:  Heiner Wedemeyer; Michael P Manns
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-01       Impact factor: 46.802

6.  Correlation of hepatitis B virus, hepatitis D virus and human immunodeficiency virus type I infection markers in hepatitis B surface antigen positive haemophiliacs and patients without haemophilia with clinical and histopathological outcome of hepatitis.

Authors:  N Wagner; H W Rotthauwe; M Becker; H P Dienes; T Mertens; H J Födisch; H H Brackmann
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

7.  Comparative sequencing of human and chimpanzee MHC class I regions unveils insertions/deletions as the major path to genomic divergence.

Authors:  Tatsuya Anzai; Takashi Shiina; Natsuki Kimura; Kazuyo Yanagiya; Sakae Kohara; Atsuko Shigenari; Tetsushi Yamagata; Jerzy K Kulski; Taeko K Naruse; Yoshifumi Fujimori; Yasuhito Fukuzumi; Masaaki Yamazaki; Hiroyuki Tashiro; Chie Iwamoto; Yumi Umehara; Tadashi Imanishi; Alice Meyer; Kazuho Ikeo; Takashi Gojobori; Seiamak Bahram; Hidetoshi Inoko
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-10       Impact factor: 11.205

8.  Suppression of hepatitis C virus (HCV) replication by hepatitis D virus (HDV) in HIV-infected hemophiliacs with chronic hepatitis B and C.

Authors:  M E Eyster; J C Sanders; M Battegay; A M Di Bisceglie
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

Review 9.  HDV Pathogenesis: Unravelling Ariadne's Thread.

Authors:  Eirini D Tseligka; Sophie Clément; Francesco Negro
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

Review 10.  Animal models of chronic hepatitis delta virus infection host-virus immunologic interactions.

Authors:  Rafael Aldabe; Lester Suárez-Amarán; Carla Usai; Gloria González-Aseguinolaza
Journal:  Pathogens       Date:  2015-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.